.png){kind=icon}
返回
Special Populations
.png){kind=icon}
PRE
AI
DOI：10.1016/j.cld.2026.01.005.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En
期刊
IF:
4.1
论文数:
121
被引数:
3.0K
机构
引用论文
Lifestyle and Pharmacologic Approaches to Prevention of Metabolic Dysfunction-associated Steatotic Liver Disease-related Hepatocellular Carcinoma生活方式和药物治疗预防代谢功能障碍相关脂肪性肝病相关肝细胞癌的方法
PREAI
分享收藏EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)Easl-easd-easo关于代谢功能障碍相关的脂肪性肝病 (MASLD) 管理的临床实践指南
PREAI
分享收藏分享收藏Regulatory T cell: a double-edged sword from metabolic-dysfunction-associated steatohepatitis to hepatocellular carcinoma调节性T细胞: 从代谢功能障碍相关的脂肪性肝炎到肝细胞癌的双刃剑.png)
EBIOMEDICINE
OAAI
EBIOMEDICINEIF10.8
OAAI分享收藏Association of Nonalcoholic Fatty Liver Disease (NAFLD) with Hepatocellular Carcinoma (HCC) in the United States From 2004 to 2009HEPATOLOGY
HEPATOLOGYIF15.8
PREAI
分享收藏Utility and limitations of noninvasive fibrosis markers for predicting prognosis in biopsy-proven Japanese non-alcoholic fatty liver disease patients无创性纤维化标志物预测活检证实的日本非酒精性脂肪肝患者预后的实用性和局限性OAAI
OAAI分享收藏Alsaqa, M.; Sierra, L.; Marenco-Flores, A.; Parraga, X.; Barba, R.; Goyes, D.; Ozturk, N.B.; Curry, M.P.; Bonder, A.; Saberi, B. Metabolic Dysfunction-Associated Steatotic Liver Disease Correlates with Higher Lower Graft Survival in Liver Transplant Recipients with Hepatocellular Carcinoma. Eur. J. Gastroenterol. Hepatol. 2025, 37, 497–504. [Google Scholar] [CrossRef] [PubMed]Alsaqa, M.; Sierra, L.; Marenco-Flores, A.; Parraga, X.; Barba, R.; Goyes, D.; Ozturk, N.B.; Curry, M.P.; Bonder, A.; Saberi, B. 代谢功能障碍相关脂肪性肝病与肝细胞癌患者肝移植术后更高的移植物存活率相关。Eur. J. Gastroenterol. Hepatol. 2025, 37, 497–504. [Google Scholar] [CrossRef] [PubMed]
IF0
PREAI
分享收藏
查看更多内容